Related Experiment Video

Updated: May 22, 2026

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
07:17

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on: August 23, 2024

TNF related apoptosis-inducing ligand and its receptors in ocular tumors

Qian Ning1, Lei Hou, Min Meng

  • 1Department of Oncology, the First hospital Affiliated to School of Medicine of Xi'an Jiaotong University, Xi'an 710061, Shaanxi Province, China.

International Journal of Ophthalmology
|May 4, 2012
PubMed

Insights

Tumor necrosis factor related apoptosis-inducing ligand (TRAIL) shows promise for treating ocular tumors. TRAIL selectively induces cancer cell death, offering a new therapeutic avenue in ophthalmology.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Immunology

Background:

  • Ocular tumors often have a poor prognosis, presenting a significant challenge in ophthalmology.
  • Advances in molecular biology and immunology enable molecular-level diagnosis and treatment of malignant tumors.

Purpose of the Study:

  • To review the structure, function, mechanism of action, and therapeutic applications of tumor necrosis factor related apoptosis-inducing ligand (TRAIL) and its receptors in ocular tumors.

Main Methods:

  • Literature review focusing on TRAIL and its receptors in the context of ocular tumors.
  • Analysis of TRAIL's mechanism in inducing apoptosis via death receptor activation.

Main Results:

  • TRAIL, a member of the tumor necrosis factor (TNF) superfamily, can initiate apoptosis.
  • TRAIL selectively induces apoptosis in transformed, virus-infected, or tumor cells, sparing normal cells.

Conclusions:

  • TRAIL presents a promising candidate for ocular tumor therapy, potentially used alone or in combination with existing treatments.
  • The selective apoptotic effect of TRAIL supports its development for targeted cancer therapies in ophthalmology.
Keywords:
apoptosisocular tumorstumor necrosis factor related apoptosis-inducing ligand

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...